Development of cancer immunotherapy in Finland is boosted by a recent 10 million € investment. Cancer IO is a new cancer research and innovation project focused on immuno-oncology (IO) therapies. #HelsinkiHealth #cancer #health #healthtech @JuhaKlefstrom https://t.co/isWwj0Rp0i
— University of Helsinki (@helsinkiuni) May 13, 2020 11:00